Confusion over French GM law

A month after Chirac said a new law was weeks away, a decision is still distant

Written byJane Burgermeister
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

France is still a long way from introducing legislation to transpose an EU directive on genetically modified (GM) crops into national law, in spite of a statement by President Jacques Chirac on October 21 that a draft law would be ready within 2 weeks.

Stephane Vaxelaire, a spokesman of the French Ministry of Agriculture, told The Scientist that draft legislation to transpose EU Directive 2001/18/EC, which covers the deliberate release into the environment of genetically modified organisms (GMOs), could not be expected until 2005.

Vaxelaire said that the government would wait for the report of a parliamentary inquiry before drafting legislation. The inquiry or "mission" to inform French deputies about the effects of GM crops began work last week and is due to present its conclusions in March or April 2005.

The EU directive introduces one of the strictest regulatory frameworks in the world for GM crops, including principles of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform